Meet the experts driving innovation at eXmoor Pharma. Our leadership, scientific, and business teams bring decades of combined experience in process development, GMP manufacturing, facility design, and consulting, working together to accelerate advanced therapies from concept to commercialisation.
About Us
Our Team
Meet Our Team
George Fotiades
Chair
Angela Osborne
Founder and Board Director
Lucy Foley
Chief Executive Officer
Ian Rhodes
Director
Graham Henderson
Chief Financial Officer and Board Observer
Gavin Sutton
Executive Director Capital Projects
Gillian Lewis
Chief Consultant
Manuel Balbuena
Chief Commercial Officer and Board Observer
Emma Ewins
Chief Operating Officer
James Miskin
Fractional Chief Technology Officer and Non-Executive Director
David Vincent
Head of Process Development
Termeh Ahmadraji
Head of Operations
Ruxandra Comisel
Business Development Manager
Helen Jones
Head of Marketing
Shailesh Maingi
Board Member, Kineticos Ventures
Mike Kilcooley
Proposal Manager
Tom Casdagli
Board Member, MVM Partners
Frank Lis
Board Observer, Kineticos Ventures
Jack Tanaka
Board Member, MVM Partners
Robert Scott
Head of Consultancy
Clare Blue
Senior CMC Translation Consultant
Vicky Smith
Translation Consultant
Harvey Branton
Senior Translation Consultant
Kate Fynes
CMC Translation Consultant
Drew Hope
Senior Bio Manufacturing & Compliance Consultant & UK QP
Evelien Stalmeijer
Chief Cell & Gene Therapy Consultant
Vittoria Ardissone
GMP Compliance Consultant and QP
Chrissy Claudius
Project Manager
John Joseph
Bioprocessing Engineering Consultant
Paul Dempsey
Architect
Andrew Besso
Senior Bioprocess Consultant
Daphné Bocciarelli
Head of Vector
Adam Janvier
Head of Cell Therapy
Corinne McEwan
Head of RNA
Gwyneth Thomas
Head of Quality
Let’s Accelerate Your Therapy Together
Whether you’re in early-stage development or scaling up for commercial production, eXmoor Pharma provides the expertise and flexibility you need. Partner with us to move your therapy forward with confidence.
Latest News
eXmoor Pharma and Evox Therapeutics complete technology transfer programme for exosome-enabled gene editing technology
eXmoor Pharma strengthens operational and technical leadership with two appointments